Literature DB >> 21674717

Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet's disease.

Yoon Suk Jung1, Jin Young Yoon, Jin Ha Lee, Soung Min Jeon, Sung Pil Hong, Tae Il Kim, Won Ho Kim, Jae Hee Cheon.   

Abstract

BACKGROUND: To date there have been few studies regarding the efficacy of surgical treatment and related prognostic factors following intestinal resection in patients with intestinal Behcet's disease (BD). Here we investigated the long-term clinical outcomes and related prognostic factors after surgical treatment for intestinal BD.
METHODS: We reviewed the medical records of 72 patients with intestinal BD who underwent surgery between March 1986 and May 2010. Prognostic factors were identified by univariate analysis using the Kaplan-Meier method, the log-rank test, and multivariate analysis using Cox proportional hazards regression models.
RESULTS: Recurrence after surgical treatment was observed in 42 (58.3%) patients and reoperations were performed in 22 (30.6%) patients. The cumulative recurrence rates after surgical treatment were 29.2% at 2 years and 47.2% at 5 years; the cumulative reoperation rates were 12.5% at 2 years and 22.2% at 5 years. Multivariate analysis identified volcano-shaped ulcers, higher C-reactive protein (CRP) levels (≥ 4.4 mg/dL), and the presence of intestinal perforations detected by pathology as independent predictive factors for recurrence. Moreover, volcano-shaped ulcers, higher CRP levels (≥ 4.4 mg/dL), and a history of postoperative steroid therapy were independent predictive factors for reoperation.
CONCLUSIONS: According to the current study, volcano-shaped ulcers, higher CRP levels, a history of postoperative steroid therapy, and the presence of intestinal perforations detected by pathology were factors of a poor prognosis. Careful follow-up is required in surgical patients with these risk factors, who are at high risk for recurrence and reoperation.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21674717     DOI: 10.1002/ibd.21517

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  37 in total

Review 1.  Behcet colitis.

Authors:  Anne B Chin; Anjali S Kumar
Journal:  Clin Colon Rectal Surg       Date:  2015-06

2.  Risk factors and outcomes of acute lower gastrointestinal bleeding in intestinal Behçet's disease.

Authors:  Jihye Park; Jae Hee Cheon; Yong Eun Park; Yoon Jee Lee; Hyun Jung Lee; Soo Jung Park; Sung Pil Hong; Tae Il Kim; Won Ho Kim
Journal:  Int J Colorectal Dis       Date:  2016-12-06       Impact factor: 2.571

3.  Preoperative Misdiagnosis of Intestinal Behçet's Syndrome as Crohn's Disease Based on Superficial Colonoscopic Biopsies: Case Report and Systematic Review.

Authors:  Seifeldin Hakim; Srinivas Ramireddy; Mitual Amin; Souheil Gebara; Mitchell S Cappell
Journal:  Dig Dis Sci       Date:  2018-08-28       Impact factor: 3.199

4.  Peripheral arterial involvement in Behcet's disease: an analysis of the results from a Korean referral center.

Authors:  Shin-Seok Yang; Keun-Myoung Park; Yang Jin Park; Young-Wook Kim; Young Soo Do; Hong Suk Park; Kwang Bo Park; Dong-Ik Kim
Journal:  Rheumatol Int       Date:  2013-02-16       Impact factor: 2.631

Review 5.  Gastrointestinal Behçet's disease: a review.

Authors:  Wasseem Skef; Matthew J Hamilton; Thurayya Arayssi
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

6.  Clinical course of intestinal Behcet's disease during the first five years.

Authors:  Yoon Suk Jung; Jae Hee Cheon; Soo Jung Park; Sung Pil Hong; Tae Il Kim; Won Ho Kim
Journal:  Dig Dis Sci       Date:  2012-08-17       Impact factor: 3.199

Review 7.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

8.  Successful treatment with infliximab for refractory para-ileostomal ulceration in a patient with Behҫet's disease.

Authors:  Mitsuaki Ishioka; Kengo Onochi; Yusato Suzuki; Masayuki Sawaguchi; Natsumi Hatakeyama; Shigeto Koizumi; Tamotsu Matsuhashi; Mario Jin; Hirohide Ohnishi
Journal:  Clin J Gastroenterol       Date:  2015-06-09

9.  The outcomes and risk factors of early readmission in patients with intestinal Behçet's disease.

Authors:  Yong Eun Park; Jae Hee Cheon; Yehyun Park; Soo Jung Park; Tae Il Kim; Won Ho Kim
Journal:  Clin Rheumatol       Date:  2017-11-07       Impact factor: 2.980

10.  Correlations between endoscopic and clinical disease activity indices in intestinal Behcet's disease.

Authors:  Hyun Jung Lee; Youn Nam Kim; Hui Won Jang; Han Ho Jeon; Eun Suk Jung; Soo Jung Park; Sung Pil Hong; Tae Il Kim; Won Ho Kim; Chung Mo Nam; Jae Hee Cheon
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.